Player Avatar EVplusEV (56.96) Submitted: 11/12/2012 12:54:31 PM : Outperform Start Price: $31.11 ABT Score: +0.15

Catalyst #1: ABT presenting at the American Association for the Study of Liver Diseases today, look for positive reports on its Hep C program. Catalyst #2: Splitting into two companies sometime after the first of the year; one pharma and one medical technology. Stock is down over 9% from the highs and with these catalysts, I'm in this on a trade with a target of $71 per share.

Featured Broker Partners